DK1267863T3 - Sammensætning, der består af propionyl-L-carnitin og glycin, til forebyggelse og/eller behandling af de cytotoksiske effekter, der induceres ved anvendelse af immunosuppressive stoffer - Google Patents

Sammensætning, der består af propionyl-L-carnitin og glycin, til forebyggelse og/eller behandling af de cytotoksiske effekter, der induceres ved anvendelse af immunosuppressive stoffer

Info

Publication number
DK1267863T3
DK1267863T3 DK01912114T DK01912114T DK1267863T3 DK 1267863 T3 DK1267863 T3 DK 1267863T3 DK 01912114 T DK01912114 T DK 01912114T DK 01912114 T DK01912114 T DK 01912114T DK 1267863 T3 DK1267863 T3 DK 1267863T3
Authority
DK
Denmark
Prior art keywords
immunosuppressants
carnitine
propionyl
glycine
prevention
Prior art date
Application number
DK01912114T
Other languages
Danish (da)
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1267863T3 publication Critical patent/DK1267863T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01912114T 2000-03-02 2001-02-20 Sammensætning, der består af propionyl-L-carnitin og glycin, til forebyggelse og/eller behandling af de cytotoksiske effekter, der induceres ved anvendelse af immunosuppressive stoffer DK1267863T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000107A IT1316998B1 (it) 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.

Publications (1)

Publication Number Publication Date
DK1267863T3 true DK1267863T3 (da) 2006-12-04

Family

ID=11454493

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01912114T DK1267863T3 (da) 2000-03-02 2001-02-20 Sammensætning, der består af propionyl-L-carnitin og glycin, til forebyggelse og/eller behandling af de cytotoksiske effekter, der induceres ved anvendelse af immunosuppressive stoffer

Country Status (19)

Country Link
US (1) US7897641B2 (hu)
EP (1) EP1267863B1 (hu)
AR (1) AR027963A1 (hu)
AT (1) ATE335476T1 (hu)
AU (2) AU2001241031B8 (hu)
CA (1) CA2400728C (hu)
CY (1) CY1106169T1 (hu)
CZ (1) CZ20022759A3 (hu)
DE (1) DE60122120T2 (hu)
DK (1) DK1267863T3 (hu)
ES (1) ES2269356T3 (hu)
HU (1) HUP0300083A3 (hu)
IT (1) IT1316998B1 (hu)
MX (1) MXPA02008531A (hu)
PL (1) PL202682B1 (hu)
PT (1) PT1267863E (hu)
SK (1) SK11892002A3 (hu)
TN (1) TNSN01032A1 (hu)
WO (1) WO2001064204A2 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106232114B (zh) * 2014-04-22 2022-03-18 味之素株式会社 周围神经病变的预防或改善用组合物
CN115469026B (zh) * 2022-07-14 2023-10-20 中日友好医院(中日友好临床医学研究所) 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
JPH0662547B2 (ja) * 1989-01-10 1994-08-17 田辺製薬株式会社 グリシン誘導体
IT1248323B (it) * 1991-05-16 1995-01-05 Sigma Tau Ind Farmaceuti Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti
IT1245869B (it) 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
US5763408A (en) * 1992-06-03 1998-06-09 Fuji Photo Film Co., Ltd. Amino acid derivatives and application thereof
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
ATE187329T1 (de) * 1996-03-04 1999-12-15 Sigma Tau Ind Farmaceuti Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliterans
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
IT1302863B1 (it) 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
IT1306173B1 (it) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
IT1307278B1 (it) * 1999-11-18 2001-10-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil
IT1317062B1 (it) * 2000-07-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare utile per prevenire le disfunzioni epatiche ebiliari comprendente una alcanoil l-carnitina.
ITRM20010155A1 (it) * 2001-03-23 2002-09-23 Biosalts Srl Sale di creatina ad aumentato valore nutrizionale e terapeutico e composizioni che lo contengono.

Also Published As

Publication number Publication date
PL202682B1 (pl) 2009-07-31
HUP0300083A2 (hu) 2003-06-28
HUP0300083A3 (en) 2004-07-28
DE60122120T2 (de) 2007-02-08
ES2269356T3 (es) 2007-04-01
WO2001064204A2 (en) 2001-09-07
SK11892002A3 (sk) 2003-02-04
AU4103101A (en) 2001-09-12
ITRM20000107A0 (it) 2000-03-02
WO2001064204A3 (en) 2002-03-28
CA2400728A1 (en) 2001-09-07
CZ20022759A3 (cs) 2003-02-12
MXPA02008531A (es) 2003-02-12
ATE335476T1 (de) 2006-09-15
TNSN01032A1 (fr) 2005-11-10
US7897641B2 (en) 2011-03-01
CA2400728C (en) 2009-04-28
AU2001241031B8 (en) 2005-12-01
PL358267A1 (en) 2004-08-09
EP1267863A2 (en) 2003-01-02
AU2001241031B2 (en) 2005-10-27
DE60122120D1 (de) 2006-09-21
US20030144354A1 (en) 2003-07-31
IT1316998B1 (it) 2003-05-26
AR027963A1 (es) 2003-04-16
EP1267863B1 (en) 2006-08-09
PT1267863E (pt) 2006-10-31
ITRM20000107A1 (it) 2001-09-02
CY1106169T1 (el) 2011-06-08

Similar Documents

Publication Publication Date Title
DK2412368T3 (da) Sammensætning til behandling af ar
DK1123313T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
AUPR105400A0 (en) Processes and compositions for water treatment
IL149030A0 (en) Pharmaceutical compositions containing rifampicin, isoniazid or combinations thereof
DK0915697T3 (da) Antikonvulsive sulfamatderivater, som er anvendelige ved behandling af fedme
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
EE05107B1 (et) Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning ühendi kasutamine
ID17401A (id) Komposisi-komposisi tinta dan pelapis yang mengandung jelaga yang diolah silikon
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
WO2003039447A3 (fr) Composition contenant un ester n-acyle d'acide amine et un filtre uv structuree par un polyamide
IS5740A (is) Samsetning sem samanstendur af karnitíni, glútaþíóni (glutathione) gagnlegu til að auka gleypni glútaþíóns og samverka áhrif þess
GB0026054D0 (en) Films,compositions and processes
DK1196046T3 (da) Sammensætning til forebyggelse af muskeltræthed og skeletmuskulaturtilpasning ved anstrengende udfoldelse
IL153359A0 (en) Peptides, compositions and methods for the treatment of burkholderia cepacia
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
DK1218022T3 (da) Sammensætning til forebyggelse og/eller behandling af kredsløbslidelser omfattende derivater af L-carnitin og ekstrakter af Ginkgo Biloba
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DK0932400T3 (da) Antikonvulsive derivater, der er nyttige ved behandling af neuropatisk smerte
NO20012428D0 (no) Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer
DK1267863T3 (da) Sammensætning, der består af propionyl-L-carnitin og glycin, til forebyggelse og/eller behandling af de cytotoksiske effekter, der induceres ved anvendelse af immunosuppressive stoffer
DK1466604T3 (da) Isoquinolinderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf ved behandling af metatoninerge problemsystemer